当前位置:首页 - 行情中心 - 科兴制药(688136) - 财务分析 - 现金流量表

科兴制药

(688136)

  

流通市值:43.29亿  总市值:43.29亿
流通股本:2.02亿   总股本:2.02亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金343,983,364.971,359,794,670.67901,682,476.95594,413,026.63
  收到的税费返还-3,153,719.031,350,046.21133,574.54
  收到其他与经营活动有关的现金2,701,449.0335,688,289.2626,422,211.7511,972,199.15
  经营活动现金流入小计346,684,8141,398,636,678.96929,454,734.91606,518,800.32
  购买商品、接受劳务支付的现金128,156,336.13402,160,745.99276,678,071.15158,054,812.72
  支付给职工以及为职工支付的现金60,064,660.7238,996,543.26177,754,043.27115,678,074.76
  支付的各项税费19,751,892.8360,910,754.4543,084,190.7529,398,545.53
  支付其他与经营活动有关的现金131,794,494.83610,539,749.47439,195,957.93273,589,284.58
  经营活动现金流出小计339,767,384.491,312,607,793.17936,712,263.1576,720,717.59
  经营活动产生的现金流量净额6,917,429.5186,028,885.79-7,257,528.1929,798,082.73
二、投资活动产生的现金流量:
  收回投资收到的现金285,000,0001,762,898,600.241,334,743,697.83801,850,000
  取得投资收益收到的现金2,714,761.5816,332,713.2412,878,974.888,537,534.55
  处置固定资产、无形资产和其他长期资产收回的现金净额125,0001,165,9701,158,970952,970
  处置子公司及其他营业单位收到的现金净额-13,499,888.7413,499,888.7413,499,888.74
  收到的其他与投资活动有关的现金128,000577,000557,000170,000
  投资活动现金流入小计287,967,761.581,794,474,172.221,362,838,531.45825,010,393.29
  购建固定资产、无形资产和其他长期资产支付的现金13,194,123.2883,626,674.8250,637,515.7629,948,715.58
  投资支付的现金299,000,0001,770,850,0001,465,850,000995,850,000
  取得子公司及其他营业单位支付的现金-1,072,4401,072,440-
  支付其他与投资活动有关的现金14,128,170.562,687,0001,142,000577,000
  投资活动现金流出小计326,322,293.841,858,236,114.821,518,701,955.761,026,375,715.58
  投资活动产生的现金流量净额-38,354,532.26-63,761,942.6-155,863,424.31-201,365,322.29
三、筹资活动产生的现金流量:
  吸收投资收到的现金-19,250,80019,250,80019,250,800
  取得借款收到的现金143,900,000916,430,061.72709,641,541.72420,679,579.9
  收到其他与筹资活动有关的现金-118,847.04118,847.04118,847.04
  筹资活动现金流入小计143,900,000935,799,708.76729,011,188.76440,049,226.94
  偿还债务支付的现金142,871,849.54732,420,199.44526,862,283.43287,615,207.89
  分配股利、利润或偿付利息支付的现金10,325,036.5957,383,991.6546,721,329.2136,442,873.67
  支付其他与筹资活动有关的现金9,863,724.272,681,420.7655,042,650.9652,175,523.77
  筹资活动现金流出小计163,060,610.33862,485,611.85628,626,263.6376,233,605.33
  筹资活动产生的现金流量净额-19,160,610.3373,314,096.91100,384,925.1663,815,621.61
四、汇率变动对现金及现金等价物的影响-2,536,495.53-210,761.57786,051.791,033,973.31
五、现金及现金等价物净增加额-53,134,208.6195,370,278.53-61,949,975.55-106,717,644.64
  加:期初现金及现金等价物余额648,322,221.12552,951,942.59552,951,942.59552,951,942.59
  期末现金及现金等价物余额595,188,012.51648,322,221.12491,001,967.04446,234,297.95
补充资料:
  净利润-152,744,259.08-78,962,472.06
  资产减值准备-2,342,216.31-978,079.61
  固定资产和投资性房地产折旧-70,268,337.55-34,413,663.76
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-70,268,337.55-34,413,663.76
  无形资产摊销-27,702,947.65-13,145,669.75
  长期待摊费用摊销-6,061,405.93-3,024,930.59
  处置固定资产、无形资产和其他长期资产的损失--954,825.69-114,723.4
  固定资产报废损失-610,458.29-113,238.67
  公允价值变动损失--79,288,219.78--15,439,757.31
  财务费用-42,847,352.41-20,135,472.81
  投资损失--30,771,240.12--23,535,525.66
  递延所得税-9,264,233.76-2,270,936.03
  其中:递延所得税资产减少--2,257,007.17-953,775.1
    递延所得税负债增加-11,521,240.93-1,317,160.93
  存货的减少-252,070.47-11,930,587.07
  经营性应收项目的减少--224,910,029.88--95,968,022.08
  经营性应付项目的增加-92,912,249.38--13,694,468.57
  其他-5,183,766.88-6,658,137
  现金的期末余额-648,322,221.12-446,234,297.95
  减:现金的期初余额-552,951,942.59-552,951,942.59
  现金及现金等价物的净增加额-95,370,278.53--106,717,644.64
公告日期2026-04-292026-04-222025-10-302025-08-23
审计意见(境内)标准无保留意见
TOP↑